Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Parity and breast cancer risk are not so strictly linked
  • News

Parity and breast cancer risk are not so strictly linked

  • 30 March 2020
  • Elena Riboldi
Parity and breast cancer risk are not so strictly linked
Total
0
Shares
0
0
0
0
0

The reduction in birth rate has been blamed in the past for the increase in breast cancer in young women, but now a study just published in JAMA Network Open (JAMA Netw Open. 2020;3(3):e200929. doi:10.1001/jamanetworkopen.2020.0929) offers evidence refuting this hypothesis: analysing data going back to the 1930s, a group led by Mary Beth Terry, professor of Epidemiology at Columbia University, concluded that the trend in breast cancer incidence in women younger than 40 years began three decades before the secular decrease in parity. Thus, the increase in breast cancer incidence cannot be attributed primarily to changes in births per woman.

“Most studies on breast cancer incidence use data from the 1970s and onward, major changes in parity, such as the increase during the baby boom, are not fully captured” explains Terry. Data from the Connecticut Tumor registry, the oldest population-based cancer registry in the United States, were cross-referenced with data from the National Vital Statistics System, an intergovernmental database that includes national birth data since 1917. In Connecticut, among women aged 25 to 39 years, breast cancer incidence increased in a statistically significant way by 0.65% per year from 1935 to 2015. Breast cancer diagnoses went from 16.3 per 100,000 women to 38.5 per 100,000 women. However, the decrease in parity started many years later: the mean parity peaked at 2.26 live births per woman in 1966 and fell to 1.41 in 2010.

“Although recent parity trends track with breast cancer incidence trends and can partially explain the increased incidence, they do not explain most of the increase, and the historical trends using a much longer time lens provide a strong argument against parity being the primary factor associated with increasing breast cancer incidence, particularly in younger women” the authors write. Since women are generally screened by mammography only after age 40 years, they also rule out mammography screening as the main cause of the increase in breast cancer incidence in youth, though they do not suggest alternative explanations.

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • breast cancer
  • children
  • motherhood
  • parity
  • pregnancy
  • risk
  • risk factors
Elena Riboldi

Previous Article
  • Articles
  • Delivery of Care

Women make great surgeons, so why is the profession still dominated by men?

  • 26 March 2020
  • Simon Crompton
View Post
Next Article
  • News

COVID-19: Cancer World editor and immunologist Adriana Albini explains how it works and how researchers are hoping to tame it

  • 31 March 2020
  • Editorial Staff
View Post
You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • News

Call-to-arms for Europe to provide essential paediatric anti-cancer medicines

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Exercise-stimulated myokine production can extend survival in advanced prostate cancer

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Five San Antonio take-aways to improve care of breast cancer patients

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Aerobic activity to outcompete metastasis 

  • Janet Fricker
  • 2 December 2022
View Post
  • News

Ending cancer inequalities: European summit showcases new tools to inform policy

  • Anna Wagstaff
  • 30 November 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • Hansjörg Senn of St Gallen: A practice-changing career
    • 3 February 2023
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.